Skip to content

Author

G. Markantes

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Genetic variants of the leptin–melanocortin pathway in a clinically selected Greek cohort with severe early-onset obesity and hyperphagia: implications for precision obesity medicine

Background Rare genetic forms of obesity are characterized by severe, early-onset obesity and hyperphagia, often involving the leptin–melanocortin pathway. Although advances in genetic testing have improved the recognition of monogenic obesity, data from Southern European populations remain limited. We investigated the...

E. Kostopoulou, D. X. Spilioti, Nikolaos D. Pantzaris et al. · 0 citations
Open access Sep 2026

Metabolic and Lipoprotein Changes in Type 2 Diabetes Patients Treated with Empagliflozin

Background/Objectives: This study evaluated the metabolic effects of empagliflozin, an SGLT2 inhibitor (SGLT2i), in type 2 diabetes patients. Methods: In an observational cohort study, 42 patients received empagliflozin for 1 month, with serum and urine analyzed for IL-6, NT-proBNP, iron metabolism markers, and electro...

Evagelia E. Habeos, G. Markantes, Anastasia Parthymou et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.